Plain-English translation of NCT03600779 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing a new MRI scanning technique called inhomogeneous Magnetisation Transfer (ihMT) that may be better at detecting damage to myelin—the protective coating around nerve fibers—in people with early multiple sclerosis. This study will compare how well this new technique works in patients with recently diagnosed MS and in healthy volunteers, using two different types of MRI machines.
Currently, doctors need better tools to monitor nerve damage and healing in MS patients, especially those taking new treatments designed to help nerves repair themselves. This new scanning technique could help track these changes more accurately and help doctors see which patients are responding to treatment.
You likely qualify if…
You likely don't qualify if…
You will undergo MRI scans using the new ihMT technique on two different types of MRI machines (one standard strength and one stronger). The scans themselves are non-invasive and painless, though you'll need to lie still inside the machine. If you're a patient participant, you'll have an initial MRI scan that includes a contrast dye injection to identify active lesions; healthy volunteers will complete similar scans for comparison purposes. The study aims to enroll 85 participants total and is currently recruiting.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France